Medication during pregnancy

被引:0
|
作者
Malbos, Damien [1 ]
机构
[1] 24 Rue Pablo Picasso, F-15000 Aurillac, France
来源
ACTUALITES PHARMACEUTIQUES | 2021年 / 60卷 / 607期
关键词
drug; fetotoxicity; pregnancy; prescription; self-medication; teratogenicity;
D O I
10.1016/j.actpha.2021.04.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Taking medication during pregnancy can have consequences on the development of the embryo and the fetus, but also on the health of the newborn. Pregnant women should review their chronic treatment with their prescriber and seek the advice of their pharmacist if they have any doubt, particularly in the case of self-medication. (C) 2021 Elsevier Masson SAS. All rights reserved
引用
收藏
页码:28 / 30
页数:3
相关论文
共 50 条
  • [1] Medication use during pregnancy
    Cragan, Janet D.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [2] MEDICATION FOR PINWORM DURING PREGNANCY
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1948, 136 (06): : 434 - 434
  • [3] Medication during pregnancy and breastfeeding
    Bobo, W.
    Stevens, A.
    Geerling, B.
    BIPOLAR DISORDERS, 2014, 16 : 58 - 58
  • [4] Emergency medication during pregnancy
    Fink, H.
    von Steinburg, S. Pildner
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2012, 107 (02) : 123 - 127
  • [5] Medication therapy during pregnancy
    Gronau, S.
    Neumann, A.
    HNO, 2012, 60 (07) : 637 - 648
  • [6] MEDICATION FOR PINWORM DURING PREGNANCY
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1948, 137 (16): : 1500 - 1500
  • [7] THE EFFECTS OF MEDICATION DURING PREGNANCY
    PARBOOSINGH, J
    CANADIAN FAMILY PHYSICIAN, 1981, 27 (JUN) : 1013 - 1015
  • [8] Medication Use During Pregnancy
    Hilas, Olga
    US PHARMACIST, 2024, 49 (09)
  • [9] CALCIUM MEDICATION DURING PREGNANCY
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1950, 143 (04): : 408 - 408
  • [10] Medication Exposures During Pregnancy and Breastfeeding
    Green, A.
    Campbell, S. C.
    Thomas, K.
    Sherwin, C. M. T.
    Spigarelli, M. G.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 704 - 704